|
Probiotic Effect on Hepatic Steatosis Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Probiotic Effect on Hepatic Steatosis conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Probiotic Effect on Hepatic Steatosis Clinical research trials and Probiotic Effect on Hepatic Steatosis health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Probiotic Effect on Hepatic Steatosis. Probiotic Effect on Hepatic Steatosis Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Probiotic Effect on Hepatic Steatosis clinical trial. Test subjects typically receive the most expert healthcare available for their Probiotic Effect on Hepatic Steatosis condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Probiotic Effect on Hepatic Steatosis  Probiotic Effect on Hepatic Steatosis
Probiotic Effect on Hepatic Steatosis
For Condition: Fatty Liver,Hepatic Steatosis
Status: Not yet recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: The purpose of this study is to evaluate the effect of a probiotic on hepatic steatosis. "Probiotics" are living bacteria given to improve health. "Hepatic Steatosis" is a condition of increased fat in the liver, and can lead to serious health problems in some persons.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - NAFLD (Non-alcoholic fatty liver disease) as diagnosed by liver biopsy; presumed diagnosis should also include: a. Elevated ASAT, ALT, or GGT; b. Negative Hep B & C serologies; c. Transferrin saturation <50%; d. Average daily alcohol intake of <2drinks/day. - Diagnosis of DM as determined by: a. Fasting plasma glucose >126 mg/dl or random plasma glucose of >200 mg/dl. Exclusion Criteria - Evidence of cirrhosis on liver biopsy; - Unable or unwilling to under go MR (magnetic resonance) procedures, i.e., metal fragments present, severe claustrophobia, over 350 lbs. - Patients requiring long-term antibiotic therapy for any reason; - Pregnant, planning to become pregnant, or nursing; - Unable or unwilling to provide informed consent; - Any cause of liver disease other than hepatic steatosis (e.g., hepatitis C, alcohol use).
Total Enrollment: 30
Location and Contact Information:
Overall Study Official:
AnnaDiehl, Principal Investigator, Johns Hopkins University
Johns Hopkins University
Baltimore, Maryland, 21205
United States
Steve Solga 410-502-7720
Additional Information:
Study ID Numbers: R21AT1305; Diehl
Study Start Date: October 2003
Record last reviewed: September 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00068094
Other Fatty Liver Studies:
1. Probiotic Effect on Hepatic Steatosis
2. Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
3. Clinical Research Network in Non-alcoholic Steatohepatitis - Pediatric Trial
4. Treatment of Nonalcoholic Steatohepatitis with Pioglitazone
Related Studies:
Other Fatty Liver Clinical Trials
Other Maryland Clinical Trials
Other Baltimore Clinical Trials
Probiotic Effect on Hepatic Steatosis
|
|
|
|
|
|
|
|
